Henri A. Termeer

This profile gathers the share dealings of Henri A. Termeer across 5 companies, led by Abiomed Inc, Genzyme Corp and Aveo Pharmaceuticals, Inc. The record holds 119 filings, for trades running from 26 April 2007 to 9 August 2016.

Both buying and selling appear: 12 purchases worth €3.6M, against 50 sales worth €47.1M. Netting one side against the other leaves €43.5M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 18 share grants and 22 option exercises. In 2016 alone, the filings show no purchases and 5 sales.

The median purchase comes to €96k. Ninety days after publication, 6 purchases show a median change of +19.4%, with the price up in 100% of them. They describe history only and say nothing certain about the share price ahead.

The record was last updated on 11 August 2016 with a share grant in Abiomed Inc. The latest purchase dates back some time: it was published 4,307 days ago, on 7 January 2015. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.